The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.
 
Richard Wayne Joseph
Consulting or Advisory Role - Nektar
 
Tara C. Gangadhar
No Relationships to Disclose
 
Igor Puzanov
No Relationships to Disclose
 
Caroline Robert
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
 
Omid Hamid
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Antoni Ribas
Stock and Other Ownership Interests - Compugen; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Merck Sharp & Dohme (Inst)
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
 
Kellie Ann Celentano
No Relationships to Disclose
 
Jill Ann Lindia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Manash Shankar Chatterjee
Employment - Merck
Travel, Accommodations, Expenses - Merck
 
David C. Turner
Employment - Merck
 
Kapil Mayawala
Employment - Merck
Stock and Other Ownership Interests - Merck; Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
 
Jeroen Elassaiss-Schaap
Employment - MSD
Consulting or Advisory Role - PD-value (Inst)
 
Dinesh Prasad de Alwis
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Xiaoyun Nicole Li
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Scot Ebbinghaus
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Soonmo Peter Kang
Employment - Merck
Stock and Other Ownership Interests - Agenus; Celgene; Celldex; Endocyte; Macrogenics; Merck; Pharmacyclics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Merck
 
Richard Kefford
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb